Opaleye Management Inc. Repare Therapeutics Inc. Transaction History

Opaleye Management Inc.

  • $390 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$4.53 - $8.41 $306,051 - $568,188
67,561 New
67,561 $318,000
Q2 2022

Aug 15, 2022
SELL
$8.45 - $14.84 $470,479 - $826,261
-55,678 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$11.38 - $21.88 $633,615 - $1.22 Million
55,678 New
55,678 $793,000

Others Institutions Holding RPTX

# of Institutions
69
Shares Held
36.8M
Call Options Held
51.7K
Put Options Held
17.7K
View Full List

About Repare Therapeutics Inc.

RPTX Quotes by TradingView
  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $145M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email